LONG-TERM OUTCOME FOLLOWING TOTAL PARATHYROIDECTOMY IN PATIENTS WITH END-STAGE RENAL-DISEASE

被引:2
|
作者
KAYE, M
ROSENTHALL, L
HILL, RO
TABAH, RJ
机构
[1] MONTREAL GEN HOSP,DEPT NUCL MED,MONTREAL H3G 1A4,QUEBEC,CANADA
[2] MONTREAL GEN HOSP,DEPT DIAGNOST RADIOL,MONTREAL H3G 1A4,QUEBEC,CANADA
[3] MONTREAL GEN HOSP,DEPT SURG,MONTREAL H3G 1A4,QUEBEC,CANADA
关键词
PARATHYROIDECTOMY; DIALYSIS; END-STAGE RENAL DISEASE;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Long-term follow up (mean 3.8 years), following elective total parathyroidectomy in thirteen patients with end-stage renal disease is described. Nine patients are alive and all except two have measurable levels of intact parathyroid hormone (PTH). One patient is mildly hyperparathyroid with PTH levels of 143 pg/ml (normal 10-65 pg/ml). All patients did well as far as their bone and mineral metabolism were concerned and there were no fractures, bone pain or metastatic soft tissue calcification. Lumbar spine bone mineral density (BMD) increased above the baseline value and femoral neck bone density was significantly greater than a matched control group of non-parathyroidectomized dialysis patients (1.097 +/- 0.140 versus 0.811 +/- 0.148 g/cm2, Z-score 1.98 +/- 1.64 versus -0.79 +/- 1.07, p <0.001). Two of the nine patients have been transplanted, both have good allograft function and show increases in BMD. We believe that these findings justify the complete removal of all parathyroid tissue for selected patients with chronic renal failure where medical therapy has failed and aluminium bone disease has been excluded. They also raise the possibility that PTH is necessary for bone loss to occur.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 50 条
  • [41] LONGITUDINAL-STUDY OF BONE MASS IN END-STAGE RENAL-DISEASE PATIENTS - EFFECTS OF PARATHYROIDECTOMY FOR RENAL OSTEODYSTROPHY
    COPLEY, JB
    HUI, SL
    LEAPMAN, S
    SLEMENDA, CW
    JOHNSTON, CC
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 (04) : 415 - 422
  • [42] IMMUNOLOGICAL MONITORING IN PATIENTS WITH END-STAGE RENAL-DISEASE
    WALTZER, WC
    BACHVAROFF, RJ
    RAISBECK, AP
    EGELANDSDAL, B
    PULLIS, C
    SHEN, L
    RAPAPORT, FT
    JOURNAL OF CLINICAL IMMUNOLOGY, 1984, 4 (05) : 364 - 368
  • [43] ANALYSIS OF SURVIVAL OF END-STAGE RENAL-DISEASE PATIENTS
    WELLER, JM
    PORT, FK
    SWARTZ, RD
    FERGUSON, CW
    WILLIAMS, GW
    JACOBS, JF
    KIDNEY INTERNATIONAL, 1982, 21 (01) : 78 - 83
  • [44] INFRAINGUINAL BYPASS IN PATIENTS WITH END-STAGE RENAL-DISEASE
    BAELE, HR
    PIOTROWSKI, JJ
    YUHAS, J
    ANDERSON, C
    ALEXANDER, JJ
    SURGERY, 1995, 117 (03) : 319 - 324
  • [45] DIAGNOSIS OF HYPOTHYROIDISM IN PATIENTS WITH END-STAGE RENAL-DISEASE
    TANG, WW
    KAPTEIN, EM
    MASSRY, SG
    AMERICAN JOURNAL OF NEPHROLOGY, 1987, 7 (03) : 192 - 197
  • [46] MULTIPLE-DOSE STUDY OF IMIPENEM CILASTATIN IN PATIENTS WITH END-STAGE RENAL-DISEASE UNDERGOING LONG-TERM HEMODIALYSIS
    BERMAN, SJ
    SUGIHARA, JG
    NAKAMURA, JM
    KAWAHARA, KK
    WONG, EGC
    MUSGRAVE, JE
    WONG, LMF
    SIEMSEN, AM
    AMERICAN JOURNAL OF MEDICINE, 1985, 78 (6A): : 113 - 116
  • [47] CHANGING RISK FACTOR DEMOGRAPHICS IN END-STAGE RENAL-DISEASE PATIENTS ENTERING HEMODIALYSIS AND THE IMPACT ON LONG-TERM MORTALITY
    COLLINS, AJ
    HANSON, G
    UMEN, A
    KJELLSTRAND, C
    KESHAVIAH, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (05) : 422 - 432
  • [48] ANESTHESIA FOR PATIENTS WITH STABLE END-STAGE RENAL-DISEASE
    DYSON, D
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1992, 22 (02) : 469 - 471
  • [49] LYMPHOKINE PRODUCTIVITY IN PATIENTS WITH END-STAGE RENAL-DISEASE
    HA, SK
    CHOI, KH
    LEE, HY
    HAN, DS
    KIDNEY INTERNATIONAL, 1989, 36 (06) : 1182 - 1182
  • [50] FUNCTIONAL STATUS OF PATIENTS WITH END-STAGE RENAL-DISEASE
    CARLSON, DM
    JOHNSON, WJ
    KJELLSTRAND, CM
    MAYO CLINIC PROCEEDINGS, 1987, 62 (05) : 338 - 344